dehydroabietic acid has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y; Gao, G; Hölscher, C; Li, EW; Qiao, Y; Wang, H; Wang, P; Xie, Z; Xu, J; Yuan, Y; Zhang, X; Zhang, Z | 1 |
1 other study(ies) available for dehydroabietic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
Topics: Abietanes; Animals; Antioxidant Response Elements; Cholesterol; Ferroptosis; Glutathione; HEK293 Cells; Heme Oxygenase-1; Humans; Kelch-Like ECH-Associated Protein 1; Lipid Peroxidation; Male; Malondialdehyde; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Phospholipid Hydroperoxide Glutathione Peroxidase; Reactive Oxygen Species; S100 Calcium-Binding Protein A4; Signal Transduction; Triglycerides | 2021 |